Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02447679
What this trial is testing

Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence

Who this might be right for
Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaAdverse Reaction to Drug+1 more
Chang Gung Memorial Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT04740918
What this trial is testing

Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)Study completedNCT00431561
What this trial is testing

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Isarna Therapeutics GmbH 141
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Early research (Phase 1)Study completedNCT02492750
What this trial is testing

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

Who this might be right for
Indolent Plasma Cell MyelomaPlasma Cell MyelomaSmoldering Plasma Cell Myeloma
Mayo Clinic 14
Early research (Phase 1)Study completedNCT01660360
What this trial is testing

Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic Cancer
PharmAbcine 26
Early research (Phase 1)Study completedNCT02926768
What this trial is testing

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungLung Diseases+1 more
Checkpoint Therapeutics, Inc. 136
Not applicableStudy completedNCT05080868
What this trial is testing

Infantile Hemangioma With Minimal or Arrested Growth : Epidemiology, Clinical Characteristics and Evolution

Who this might be right for
Hemangioma, Capillary
Central Hospital, Nancy, France 224
Early research (Phase 1)Study completedNCT02914990
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of BPI-15086 in EGFR T790M Mutation-positive NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 36
Early research (Phase 1)Study completedNCT02499224
What this trial is testing

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Who this might be right for
Solid Tumors
CellabMED 39
Not applicableEnded earlyNCT00216814
What this trial is testing

Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors

Who this might be right for
Bladder Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 220
Not applicableUnknownNCT00671385
What this trial is testing

Survey of Optical Values of the Breast Using Radiation-Free Pressure-Free Optical Scanning

Who this might be right for
Breast LesionsBreast CystEarly-Stage Breast Cancer+1 more
Spectros Corporation 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00444678
What this trial is testing

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
NYU Langone Health 36
Not applicableStudy completedNCT02293733
What this trial is testing

Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
NSCLC Non Small Cells Lung Cancer
Groupe Francais De Pneumo-Cancerologie 144
Testing effectiveness (Phase 2)WithdrawnNCT04576208
What this trial is testing

Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Takeda
Not applicableLooking for participantsNCT07108517
What this trial is testing

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth

Who this might be right for
Breast CancerColon CancerHead and Neck Cancers
Centre for Research and Technology Hellas 180
Testing effectiveness (Phase 2)UnknownNCT03126799
What this trial is testing

Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)

Who this might be right for
EGFR Positive Non-small Cell Lung Cancer
National Cancer Center, Korea 128
Not applicableStudy completedNCT02386384
What this trial is testing

TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure

Who this might be right for
InfertilityRecurrent Pregnancy Loss
Eastern Virginia Medical School 15
Testing effectiveness (Phase 2)Study completedNCT02370849
What this trial is testing

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Chinese Academy of Medical Sciences 2
Next Page